Skip to main content
BIO logo

Bio-Rad Laboratories Inc - Class A

Exchange: NYSESector: HealthcareIndustry: Medical Devices

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.

Did you know?

Earnings per share grew at a -13.1% CAGR.

Current Price

$292.23

+1.41%

GoodMoat Value

$938.27

221.1% undervalued
Profile
Valuation (TTM)
Market Cap$7.88B
P/E10.37
EV$6.99B
P/B1.06
Shares Out26.97M
P/Sales3.05
Revenue$2.58B
EV/EBITDA7.40

Bio-Rad Laboratories Inc - Class A (BIO) — Earnings Call Transcripts

40 earnings call transcripts available.

Latest Transcript

Q4 2025 Earnings Call

9 speakers4,486 words29 segments
Read →